Press Release | July 11, 2022
Pliant Therapeutics Announces Positive Safety and Efficacy Data from Phase 2a INTEGRIS-IPF Clinical Trial of PLN-74809 in Patients with Idiopathic Pulmonary Fibrosis
Read More
Press Release | July 5, 2022
Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets
Read More
Press Release | June 21, 2022
Carbon Biosciences Launches with $38 Million Series A Financing to Advance Novel Gene Therapy Platform and Pipeline
Read More
Press Release | June 13, 2022
ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunotherapeutic Pipeline
Read More
